Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Free Cash Flow (2021 - 2025)

Historic Free Cash Flow for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to $37.0 million.

  • Molecular Partners Ag's Free Cash Flow fell 110.7% to $37.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$67.2 million, marking a year-over-year decrease of 19963.11%. This contributed to the annual value of -$68.1 million for FY2024, which is 20346.61% down from last year.
  • Per Molecular Partners Ag's latest filing, its Free Cash Flow stood at $37.0 million for Q3 2025, which was down 110.7% from -$35.8 million recorded in Q2 2025.
  • Over the past 5 years, Molecular Partners Ag's Free Cash Flow peaked at $157.0 million during Q2 2022, and registered a low of -$156.6 million during Q3 2022.
  • Over the past 5 years, Molecular Partners Ag's median Free Cash Flow value was -$18499.0 (recorded in 2025), while the average stood at $1.2 million.
  • Over the last 5 years, Molecular Partners Ag's Free Cash Flow had its largest YoY gain of 63309.0% in 2022, and its largest YoY loss of 37579.31% in 2022.
  • Molecular Partners Ag's Free Cash Flow (Quarter) stood at -$99.6 million in 2021, then skyrocketed by 222.23% to $121.7 million in 2022, then crashed by 45.85% to $65.9 million in 2023, then tumbled by 203.75% to -$68.4 million in 2024, then skyrocketed by 154.1% to $37.0 million in 2025.
  • Its Free Cash Flow stands at $37.0 million for Q3 2025, versus -$35.8 million for Q2 2025 and -$18499.0 for Q1 2025.